Burles A Johnson Iii
4PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 07, 2026
Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.Akhilesh Mishra, Ajay Kumar Sharma, Kuldeep Gupta
|Oct 27, 2025
Intratumoral Expression of a Composite B Cell / CD8 T Cell Biomarker Stratifies Overall Survival by Circulating Tumor DNA Status and Benefit From Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Carcinoma.Roy Elias, Adam K Aragaki, Jean H Hoffman-Censits
|Sep 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.Howard L Li, Soren Charmsaz, Mari Nakazawa
|Aug 19, 2025
Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer.Evangelia Vlachou, Burles A Johnson, David J McConkey
Pageof 1
Frequent Collaborators
3 joint publications
Jean Hoffman-Censits
1 joint publications
Howard L Li
1 joint publications
Soren Charmsaz
1 joint publications
Mari Nakazawa
1 joint publications
Stephanie L Alden
1 joint publications
Madelena Brancati
1 joint publications
James M Leatherman
1 joint publications
Ervin Griffin
1 joint publications
Hua-Ling Tsai
1 joint publications
Nicole E Gross
